Global Transcatheter Heart Valve Therapies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Transcatheter heart valve therapies refer to minimally invasive procedures used to treat heart valve diseases, such as aortic stenosis or mitral regurgitation, without the need for open-heart surgery. During these procedures, a collapsible artificial valve is inserted into the heart via a catheter, typically through a blood vessel in the groin or chest. Once in position, the valve is expanded, replacing the damaged or diseased native valve and restoring proper blood flow. These innovative therapies offer significant advantages over traditional surgical approaches, including reduced recovery times, fewer complications, and improved outcomes for patients deemed high-risk or inoperable for conventional surgery.

According to our Researcherlatest study, the global Transcatheter Heart Valve Therapies market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Transcatheter Heart Valve Therapies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Transcatheter Heart Valve Therapies market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2019-2030
Global Transcatheter Heart Valve Therapies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2019-2030
Global Transcatheter Heart Valve Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2019-2030
Global Transcatheter Heart Valve Therapies market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcatheter Heart Valve Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Heart Valve Therapies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, Hanyu Medical, Valgen Medtech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Transcatheter Heart Valve Therapies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Restorative Interventional Devices
Replacement Interventional Devices
Market segment by Application
Hospital
Clinic

Major players

covered
Abbott
Edwards Lifesciences
Mitralign
Cardiac Dimensions
NeoChord
Hanyu Medical
Valgen Medtech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Transcatheter Heart Valve Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transcatheter Heart Valve Therapies, with price, sales quantity, revenue, and global market share of Transcatheter Heart Valve Therapies from 2019 to 2024.
Chapter 3, the Transcatheter Heart Valve Therapies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transcatheter Heart Valve Therapies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Transcatheter Heart Valve Therapies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transcatheter Heart Valve Therapies.
Chapter 14 and 15, to describe Transcatheter Heart Valve Therapies sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions